IFNG and primary cutaneous T-cell non-Hodgkin lymphoma: Impaired cell-mediated immunity and decreased production of IFN-γ may be due to IL-12 deficiency [33] or a Th2 cytokine profile inhibiting the Th1 response in CTCL patients [9].